Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

RSS feed

Pharmacopoeia

Pharmacopoeias for the manufacture of homeopathic and anthroposophic medicinal products

ECHAMP response

to the public consultation on the structures of excise duties applied to alcohol and alcoholic beverages

ECHAMP response

to the public consultations on possible activities under a "Commission Communication on a One Health Action Plan to support Member States in the fight against Antimicrobial Resistance (AMR)"

Media reports on death of child in Italy treated with homeopathy

There has been significant media coverage over the last few days of the death of a seven year old boy in Italy. The media reports that he died of encephalitis (inflammation of the brain) as a result of a serious ear infection treated only with homeopathy. The story was released to the Italian media on Saturday 27 May and has received much coverage in Italy but also in Germany, Spain and France.

Use of homeopathy worldwide

A new study confirms that each year a significant percentage of the general population uses homeopathy, including visits to homeopaths and purchase of over-the-counter homeopathic medicines.

ECHAMP response

to the HMPWG public consultation "2nd List of First Safe Dilutions (FSD)"

April 2017

CEO workshop, Membership Assembly, Regulatory affairs

March 2017

Board of Management, regulatory environment

HMPWG consultations

ECHAMP is collating feedback on the second list of First Safe Dilutions for the HMPWG. ECHAMP’s comments on two further consultations – the Questions and Answers on Quality, and the Fifth list of justified stocks – are now available on the ECHAMP website.

HMPWG minutes

The minutes of the HMPWG meeting 10-11 November 2016 acknowledge ECHAMP’s communication on the need for transparency and the quality of the newly translated answers to frequently asked questions from Homeopathy Research Institute.

ECHAMP response

to the HMPWG public consultation "Questions and answers document on HMPWG quality of homeopathic medicinal product (Q 1-3)"

ECHAMP response

to the HMPWG public consultation "fifth list entries of stocks for which homeopathic use is justified"